Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act
-
Group Letter Opposing Section 2527(b) of the US Innovation and Competition Act (USICA)
-
Group Sign-On Letter Regarding Telehealth Extension Legislation
-
Amicus brief for HHS v Louisiana Stay (SCOTUS) – CMS Vaccination Requirements
-
Amicus Brief for Biden v Missouri Stay (CA8) – CMS Vaccination Requirements
-
Group Sign-On Letter Concerning the VA Supremacy Project
-
ACMG Joins Amicus Brief in Support of Federal Contractor Vaccination Requirements
-
Amicus brief for Biden v Missouri (8th Circuit) – CMS Vaccination Requirements